Literature DB >> 2795107

Marchiafava-Bignami disease with recovery diagnosed by CT and MRI: demyelination affects several CNS structures.

R Baron1, K Heuser, G Marioth.   

Abstract

Marchiafava-Bignami disease (MBD) is a rare complication of chronic alcoholism. Most reported cases have been diagnosed at autopsy. With CT and, especially, MRI it is possible to diagnose MBD in its early stages. Lesions of CNS structures other than the typical demyelination of the corpus callosum are described ante mortem in a patient with MBD. The more frequent use of CT and MRI in sudden onset encephalopathies of alcoholics could reveal the real incidence of MBD, and the consequent detection of other involved CNS systems might improve our knowledge about the aetiology, pathogenesis, prognosis and therapy of MBD.

Entities:  

Mesh:

Year:  1989        PMID: 2795107     DOI: 10.1007/bf00314384

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Central demyelination of the corpus callosum (Marchiafava-Bignami disease) with report of a second case in Great Britain.

Authors:  R IRONSIDE; F D BOSANQUET; W H McMENEMEY
Journal:  Brain       Date:  1961-06       Impact factor: 13.501

2.  Computerized tomography and MRI in Marchiafava-Bignami disease.

Authors:  S Bracard; D Claude; H Vespignani; M Almeras; M Carsin; H Lambert; L Picard
Journal:  J Neuroradiol       Date:  1986       Impact factor: 3.447

3.  Marchiafava-Bignami disease. A case studied by CT and MR imaging.

Authors:  E Clavier; J Thiebot; T Delangre; D Hannequin; M Samson; M Benozio
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

4.  Corpus callosum transection reduces binocularity of cells in the visual cortex of adult cats.

Authors:  U Yinon; M Chen; S Zamir; S Gelerstein
Journal:  Neurosci Lett       Date:  1988-10-17       Impact factor: 3.046

5.  Marchiafava-Bignami disease in a non-alcoholic Indian male.

Authors:  A S Leong
Journal:  Pathology       Date:  1979-04       Impact factor: 5.306

6.  A case of Marchiafavabignami disease with clinical recovery.

Authors:  C M Leventhal; J R Baringer; B G Arnason; C M Fisher
Journal:  Trans Am Neurol Assoc       Date:  1965

7.  Marchiafava-Bignami disease.

Authors:  M Dilmac; H Klein
Journal:  Acta Neuropathol Suppl       Date:  1981

8.  Perceptual unity of the ambient visual field in human commissurotomy patients.

Authors:  C Trevarthen; R W Sperry
Journal:  Brain       Date:  1973-09       Impact factor: 13.501

9.  A non-alcoholic Japanese patient with Wernicke's encephalopathy and Marchiafava-Bignami disease.

Authors:  K Kosaka; M Aoki; N Kawasaki; Y Adachi; I Konuma; R Iizuka
Journal:  Clin Neuropathol       Date:  1984 Nov-Dec       Impact factor: 1.368

10.  Marchiafava-Bignami disease. First case in germany.

Authors:  G F Walter
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-10-09
View more
  5 in total

1.  Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study.

Authors:  Anna Gambini; Andrea Falini; Lucia Moiola; Giancarlo Comi; Giuseppe Scotti
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

Review 2.  Clinicoradiologic subtypes of Marchiafava-Bignami disease.

Authors:  Alexander Heinrich; Uwe Runge; Alexander V Khaw
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

3.  Marchiafava-Bignami disease. A case studied by structural and functional brain imaging.

Authors:  T Humbert; P De Guilhermier; C Maktouf; G Grasset; F M Lopez; P Chabrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

4.  The corpus callosum in communicating and noncommunicating hydrocephalus.

Authors:  E Hofmann; T Becker; M Jackel; D Metzner; M Schneider; J Meixensberger; H Reichmann
Journal:  Neuroradiology       Date:  1995-04       Impact factor: 2.804

Review 5.  Human alcohol-related neuropathology.

Authors:  Suzanne M de la Monte; Jillian J Kril
Journal:  Acta Neuropathol       Date:  2013-12-27       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.